REGENXBIO
Employee Participants10
Total Rating191
Revenue$0
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. Read More
Headquarters 9712 Medical Center Drive, Suite 100, Rockville, MD, USA
Website http://regenxbio.com
Phone Number (202) 785-7438
